Optimal Duration of Dual Antiplatelet Therapy After Stent-assisted Coiling
NCT05257824 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 528
Last updated 2025-12-19
Summary
Comparison of duration of dual antiplatelet therapy after stent-assisted coiling of unruptured intracranial aneurysms
Conditions
- Aneurysm Cerebral
- Endovascular Procedures
Interventions
- DRUG
-
Aspirin 100mg
1. short-term dual antiplatelet: dual antiplatelet agents for 6 months 2. long-term dual antiplatelet: dual antiplatelet agents for 12 months
- DRUG
-
Clopidogrel 75mg
1. short-term dual antiplatelet: dual antiplatelet agents for 6 months 2. long-term dual antiplatelet: dual antiplatelet agents for 12 months
Sponsors & Collaborators
-
Pusan National University Yangsan Hospital
collaborator OTHER -
Keimyung University Dongsan Medical Center
collaborator OTHER -
Uijeongbu St. Mary's Hospital
collaborator UNKNOWN -
Chungnam National University Sejong Hospital
collaborator OTHER -
Soonchunhyang University Hospital
collaborator OTHER -
Asan Medical Center
collaborator OTHER -
Gangnam Severance Hospital, Yonsei University College of Medicine
collaborator UNKNOWN -
Seoul National University Bundang Hospital
lead OTHER
Principal Investigators
-
O-Ki Kwon · Seoul National University Bundang Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 19 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-06-23
- Primary Completion
- 2025-12-02
- Completion
- 2025-12-02
Countries
- South Korea
Study Locations
More Related Trials
-
Synergy Between Stent and Drugs to Avoid Ischemic Recurrences After Percutaneous Coronary Intervention
NCT00611286 ·Status: COMPLETED ·Phase: PHASE4
-
Optimizing Aspirin and Clopidogrel Therapy (BOchum CLopidogrel and Aspirin Plan)
NCT01212302 ·Status: COMPLETED ·Phase: NA
-
Clopidogrel With Aspirin in High-risk Patients With Acute Non-disabling Cerebrovascular Events II
NCT04078737 ·Status: COMPLETED ·Phase: PHASE3
-
The Prevention of Thromboembolic Complications Associated With Coil Embolization
NCT05512546 ·Status: COMPLETED
-
Double Randomization of a Monitoring Adjusted Antiplatelet Treatment Versus a Common Antiplatelet Treatment for DES Implantation, and Interruption Versus Continuation of Double Antiplatelet Therapy
NCT00827411 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Aspirin and Clopidogrel in the Atrial Fibrillation With Low or Moderate Stroke Risk
NCT02960126 ·Status: UNKNOWN ·Phase: PHASE3
-
Assessment of Quitting Versus Using Aspirin Therapy In Patients Treated With Oral Anticoagulation for Atrial Fibrillation or Other Indication With Stabilized Coronary Artery Disease
NCT04217447 ·Status: TERMINATED ·Phase: PHASE3
-
INdobufen Versus asPirin in Endovascular Unruptured Intracranial Aneurysms Treatment (INPUT)
NCT07089862 ·Status: RECRUITING ·Phase: NA
-
Perioperative Antiplatelet Therapy in Patients With Drug-eluting Stent Undergoing Noncardiac Surgery
NCT02797548 ·Status: COMPLETED ·Phase: PHASE4
-
Aspirin Treatment for Small Unruptured InTracranial Aneurysms With Ischemic cereBrovascuLar diseasE
NCT05907902 ·Status: UNKNOWN ·Phase: PHASE3
-
Reversal of Dual Antiplatelet Therapy With Cold Stored Platelets
NCT03787927 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
The Impact of Early Surgery and Maintenance of Antiplatelet Therapy on Intraoperative Bleeding and Major Adverse Cardiovascular Event After Percutaneous Coronary Intervention
NCT02941588 ·Status: COMPLETED
-
The Middle East Dual Anti-platelet Treatment in Acute Transient Ischemic Attack
NCT02144831 ·Status: WITHDRAWN ·Phase: PHASE4
-
Apixaban Versus Dual-antiplatelet Therapy (Clopidogrel and Aspirin) in Acute Non-disabling Cerebrovascular Events
NCT01924325 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Monitoring Response to Antiplatelet Therapy
NCT00327041 ·Status: UNKNOWN
-
Impact of Combination of Clopidogrel With Aspirin on Postoperative Bleeding in Coronary Surgical Patients
NCT01216150 ·Status: COMPLETED
-
Does Early Re-administration of Aspirin/Clopidogrel Increase the Risk of Bleeding From Artificial Ulcer After EMR or ESD?
NCT01621451 ·Status: UNKNOWN ·Phase: PHASE4
-
ASA- and Clopidogrel-Responsiveness in Patients With Peripheral Arterial Occlusive Disease and Interventional Procedures
NCT00593762 ·Status: SUSPENDED
-
Bleeding Time Study With AZD6482, Clopidogrel and ASA
NCT00853450 ·Status: COMPLETED ·Phase: PHASE1
-
Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD)
NCT04624854 ·Status: COMPLETED ·Phase: PHASE4
-
Acetylsalicylic Acid Plus Intensive Blood Pressure Treatment in Patients With Unruptured Intracranial Aneurysms
NCT03063541 ·Status: UNKNOWN ·Phase: PHASE3
-
Aspirin vs Clopidogrel After TAVR
NCT05493657 ·Status: RECRUITING ·Phase: NA
-
Dual Antiplatelet Therapy Versus Oral Anticoagulation for a Short Time to Prevent Cerebral Embolism After TAVI
NCT01642134 ·Status: COMPLETED ·Phase: PHASE4
-
Optimal PERioperative Antiplatelet Therapy Investigation ON Abdominal Surgery After Coronary Stent Implantation
NCT06723145 ·Status: RECRUITING ·Phase: PHASE4
-
Platelet Hyperreactivity to Aspirin and Stroke
NCT00766896 ·Status: COMPLETED ·Phase: PHASE4